Monday 18th April 2016

(8 years ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Mark Durkan Portrait Mark Durkan (Foyle) (SDLP)
- Hansard - -

It is a pleasure to speak in this debate under your chairmanship, Sir Edward. I apologise to other Members: I was not here for the start of the debate because I was upstairs in a Delegated Legislation Committee dealing with the code of practice under the Modern Slavery Act 2015, so unfortunately I did not hear what by all accounts was a powerful speech by the hon. Member for Warrington North (Helen Jones). I want to thank her not only for her role in securing today’s debate, but for the quality of the Petitions Committee report, “Funding for research into brain tumours”.

I was delighted to be here for the contribution by the hon. Member for Castle Point (Rebecca Harris), whose work as chair of the all-party group on brain tumours I admire and, as a member of the group, try to support. I thank Maria Lester for the petition, which is welcome and gives us the chance to follow up on the work done by so many other people to point out exactly how little funding goes into research into brain tumours compared with other cancers. The statistics have been quoted again and again today. I can do my little bit as well, but no matter how many times the statistics are quoted they do not become cliché-worn. It is still a shock when we consider the impact that brain tumours have.

[Ms Karen Buck in the Chair]

Brain tumours represent 1% of cancer diagnoses and 3% of cancer deaths. They also represent 2% of all deaths under 60, so that shows us what we are dealing with. It is shocking that the Government persist in committing relatively little to specifically support research into brain tumours. That is why I want to thank Brain Tumour Research for its work in Parliament and so many other places to raise awareness and funds, and then to have those funds applied to excellent work that hopefully can transform prospects for many people.

Like others, I have been contacted by constituents about this debate, including by Anne-Marie, who wrote to me about her husband, who is 45 and was diagnosed with a glioblastoma last August. She has pointed out the major effort going on in the United States via the “moonshot” campaign, which received a lot of attention after the tragic death of Joe Biden’s son. She referred me to some of the letters that were written to Joe Biden in the context of the “moonshot” campaign. She said she identified strongly with some of those letters, which spelled out the frustrations and feelings that she and her husband experienced. Our efforts should not just be about ensuring that more funding goes into research per se. We must ensure that it incentivises new treatments and fosters and facilitates innovation. Doing one will help us do the others; it will make such a huge difference.

One of the reasons why my constituents are so aware of brain tumours at the moment is that the top-class footballer Mark Farren, a young man of 33, died in February. He was a record-setting and record-breaking goal scorer who played for Derry City and Glenavon. He tragically lost his battle, even though the football family—not just those in Ireland, but people here such as Wayne Rooney, Roy Keane and others—raised money to help to get innovative treatment for him. He lost his battle, but the fight goes on.